PubMed Health⌕ Search

PubMed · 12674956

Allograft dysfunction post renal transplant.

Abstract

This case illustrates the dilemmas encountered when diagnosing and treating renal allograft dysfunction. Two of the three intended patient outcomes have been achieved. The second outcome is partially achieved in that the patient has stable renal function but still has some allograft dysfunction related to chronic calcineurin inhibitor toxicity. The most important nursing interventions in this case were emotional support, patient education, and involvement of the patient and wife in the therapeutic decisions. Although clinical assessment is very important in the care of posttransplant recipients, the most definitive tool for diagnosing allograft dysfunction is renal biopsy.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Pat Weiskittel. 2003. Allograft dysfunction post renal transplant.. https://pubmed.ncbi.nlm.nih.gov/12674956/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Non-radical diagnostic biopsies do not negatively influence melanoma patient survival.

BACKGROUND: In fair-skinned Caucasian populations both the incidence and mortality rates of cutaneous melanoma have been increasing over the past decades. With adjuvant therapies still being under investigation, early detection is the only way to improve melanoma patient survival. The influence of incisional biopsies on melanoma patient survival has been discussed for many years. This study investigates both the influence of diagnostic biopsy type and the presence of residual tumor cells in the re-excision specimen on disease free and overall survival. METHODS: After (partial) removal of a pigmented skin lesion 471 patients were diagnosed with stage I/II melanoma and underwent re-excision and a sentinel node biopsy. All patients were followed prospectively, mean follow up >5 years. Patients were divided according to their diagnostic biopsy type (wide excision biopsy, narrow excision biopsy, excision biopsy with positive margins and incisional biopsy) and the presence of residual tumor cells in their re-excision specimen. Survival analysis was done using Cox's proportional hazard model adjusted for eight important confounders of melanoma patient survival. RESULTS: The diagnostic biopsy was wide in 279 patients, narrow in 109 patients, 52 patients underwent an excision biopsy with positive margins and 31 patients an incisional biopsy. In 41 patients residual tumor cells were present in the re-excision specimen. Both the diagnostic biopsy type and the presence of tumor cells in the re-excision specimen did not influence disease free and overall survival of melanoma patients. CONCLUSIONS: Non-radical diagnostic biopsies do not negatively influence melanoma patient survival.

Biopsy↗